Tilray Brands (TLRY) Long-Term Investments (2018 - 2026)
Tilray Brands' (TLRY) quarterly Long-Term Investments came in at $6.6 million in Q2 2026, down 35.34% YoY from $10.1 million in Q2 2025, and down 14.19% on a QoQ basis from $7.6 million in Q1 2026.
Tilray Brands (TLRY) Long-Term Investments (2018 - 2026) Analysis & Trends
Tilray Brands (TLRY) has 9 years of Long-Term Investments data on file, last reported at $6.6 million in Q2 2026.
- Quarterly Long-Term Investments fell 35.34% year-over-year to $6.6 million in Q2 2026, while the trailing twelve-month figure through May 2026 was $6.6 million (down 35.34% YoY) and the FY2026 annual result came in at $6.6 million, down 35.34% from the prior year.
- Long-Term Investments slipped to $6.6 million in Q2 2026, from $7.6 million in the prior quarter.
- In the past five years, Long-Term Investments ranged from a high of $133.2 million in Q1 2022 to a low of $6.6 million in Q2 2026.
- A 5-year average of $15.9 million and a median of $8.0 million in 2023 frame the typical range for Long-Term Investments.
- Annual changes were most pronounced in 2022 — Long-Term Investments plunged 95.24% — and 2025, when it soared 80.6%.
- Tracing TLRY's Long-Term Investments over 5 years: stood at $8.2 million in 2022, then slipped by 2.16% to $8.0 million in 2023, then slipped by 7.69% to $7.4 million in 2024, then soared by 80.6% to $13.4 million in 2025, then sank by 51.09% to $6.6 million in 2026.
- The last three Long-Term Investments figures came in at $6.6 million (Q2 2026), $7.6 million (Q1 2026), and $13.4 million (Q4 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.91 Bn | 42.95 Bn | - | 92.58 Mn |
| 2 | Teva Pharmaceutical Industries | 42.98 Bn | 39.32 Bn | 2.15 Bn | - |
| 3 | Zoetis | 31.53 Bn | 29.86 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | 63.23 Mn |
| 5 | United Therapeutics | 22.16 Bn | 19.49 Bn | 683.80 Mn | 1.14 Bn |
| 6 | Viatris | 18.74 Bn | 17.85 Bn | 1.46 Bn | - |
| 7 | Neurocrine Biosciences | 15.51 Bn | 15.12 Bn | 935.80 Mn | 149.10 Mn |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.95 Bn | - | 60.00 Mn |
| 10 | Tilray Brands | 513.87 Mn | 279.24 Mn | 90.52 Mn | 6.55 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| May 31, 2026 | 6.55 Mn |
| Feb 28, 2026 | 7.63 Mn |
| Nov 30, 2025 | 13.39 Mn |
| Aug 31, 2025 | 10.17 Mn |
| May 31, 2025 | 10.13 Mn |
| Nov 30, 2024 | 7.42 Mn |
| Aug 31, 2024 | 7.85 Mn |
| May 31, 2024 | 7.86 Mn |
| Feb 29, 2024 | 8.06 Mn |
| Nov 30, 2023 | 8.03 Mn |
| Aug 31, 2023 | 7.56 Mn |
| May 31, 2023 | 7.80 Mn |
| Feb 28, 2023 | 7.62 Mn |
| Nov 30, 2022 | 8.21 Mn |
| Aug 31, 2022 | 8.88 Mn |
| May 31, 2022 | 10.05 Mn |
| Feb 28, 2022 | 133.16 Mn |
| Nov 30, 2021 | 168.24 Mn |
| Aug 31, 2021 | 186.41 Mn |
| May 31, 2021 | 17.69 Mn |